A large portion of cancer patients who try medical marijuana find it highly effective for symptom relief, a new survey…
Browsing: Medicinal
A-beta, a substance suspected as a prime culprit in Alzheimer’s disease, may start impairing learning and memory long before plaques…
London, UK; 17 June 2014: GW Pharmaceuticals a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its…
A nearly 10-year long study conducted by researchers at California Pacific Medical Center’s Research Institute, and published this month by…
Sao Paulo, Brazil: The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, controls sleep disorders in patients with Parkinson’s disease (PD),…
A new study e-published ahead of print by Neuropsychopharmacology, the official publication of the American College of Neuropsychopharmacology, has determined…
Maintaining “robust” encendocannabinoid signaling – which can be done through through the intake of cannabinoids – may provide protection against…
A study published in last month’s issue of the journal Schizophrenia Research has found that cannabis use, regardless of how…
A new study published in this month’s issue of the journal Kidney International, and published online by the U.S. National…
22 May 2014 | Denver, CO: Democrat Gov. John Hickenlooper on Wednesday approved legislation to fund observational and clinical research…
